FMR LLC - 27 Feb 2026 SCHEDULE 13G/A Report for 10x Genomics, Inc. CLASS A COMMON STOCK (TXG)

Filing Manager
FMR LLC
Reporting Manager
FMR LLC
Symbol
TXG
Shares outstanding
118,868,985 shares
Disclosed Ownership
18,543,562 shares
Ownership
16%
Form type
SCHEDULE 13G/A
Filing time
06 Mar 2026, 10:16:29 UTC
Date of event
27 Feb 2026
Previous filing
08 Jan 2026

Quoteable Key Fact

"FMR LLC disclosed 16% ownership in 10x Genomics, Inc. CLASS A COMMON STOCK (TXG) on 27 Feb 2026."

Quick Takeaways

  • FMR LLC filed SCHEDULE 13G/A for 10x Genomics, Inc. CLASS A COMMON STOCK (TXG).
  • Disclosed ownership: 16%.
  • Date of event: 27 Feb 2026.

What Changed

  • Previous schedule filing date: 08 Jan 2026.
  • Current filing was accepted on 06 Mar 2026, 10:16.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
FMR LLC 16% 18,543,562 18,506,782 0 Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Abigail P. Johnson 16% 18,543,562 0 0 Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .